Neuroblastoma patient treated at both Advocate and Comer hospitals thanks to new CCHA partnership

Image of pediatric neuroblastoma patient Jakari Fuller

When Jakari Fuller developed pneumonia at age 9, his doctor suspected the boy might have fluid buildup in his chest. Tests at Advocate Children’s Hospital in Oak Lawn uncovered something much worse: a cancerous tumor, larger than a grapefruit, in his abdomen. The tumor wound around his diaphragm and crept near his heart.

Jakari was diagnosed in 2021 with high-risk neuroblastoma, a childhood cancer that forms in nerve cells. He’s undergoing treatment at two different hospitals thanks to a new collaboration, the Chicagoland Children’s Health Alliance (CCHA).

Advocate Children’s Hospital, University of Chicago Medicine Comer Children’s Hospital and NorthShore University Health System recently partnered to create the CCHA. It allows the three hospital systems to coordinate leading-edge care for pediatric patients. It also enables close collaborations among experts in such areas as oncology, cardiology, gastroenterology and neurology.

“Teams of physicians from both hospitals work together to ensure the care is patient-centric,” said Comer Children's pediatric oncologist Susan L. Cohn, MD. “Patients really appreciate being able to receive some of their care closer to home. It is important for a cancer patient to have a doctor close to home, because if they develop a fever, antibiotics must be administered quickly.”

Jakari received his initial chemotherapy at Advocate Children’s Hospital. Shortly after his diagnosis, a multidisciplinary team of doctors from different CCHA hospitals held virtual meetings to discuss the optimal treatment for him.

Since Comer Children’s Hospital has a number of neuroblastoma specialists with specific expertise in stem cell transplant — including pediatric surgeon Grace Mak, MD, and pediatric oncologists Cohn, Ami V. Desai, MD, and James LaBelle, MD, PhD — the physicians decided it would be best for him to have his complex, specialized cancer therapies at Comer Children's, including tandem stem cell transplant surgeries. His other cancer treatments, including chemotherapy and immunotherapy, would be done at Advocate, closer to Jakari’s home in Calumet City.

Doctors from both hospitals worked as a team. When Jakari had a reaction to an immunotherapy drug, his doctors from Comer and Advocate quickly convened on a call and came up with a solution. They also devised together a treatment schedule and met frequently on Zoom to discuss his progress. All can access his medical file of test results and appointment notes.

“Jakari is one of many patients who have benefited from this close partnership, which ensures each patient is able to receive the care they need,” Cohn said. “Our patients greatly benefit from being part of a system in which multiple physicians collaborate closely to develop optimal treatment plans.”

CCHA helped make communication and collaboration between hospitals much smoother, said